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Abstract
The insights from an international scoping review provided by Lehoux et al challenge health policy-makers, 
entrepreneurs/innovators and users of healthcare, worldwide, to be aware of equity and sustainability challenges 
at system-level when appraising responsible innovation in health (RIH) – purposefully designed to better support 
health systems.The authors manage to extract no less than 1391 health system challenges with those mostly cited 
pertaining to service delivery, human resources, leadership and governance. Countries were classified according 
to the Human Development Index (HDI), while the authors decided not to classify according to the types of 
health systems justifying this on the basis that the articles reviewed studied a specific setting within a broader 
national or regional health system. The article presents highly powerful and discerning viewpoints, indeed 
providing numerous standpoints, yet in a comprehensive manner, thereby putting structure to a somewhat 
highly complex and multidimensional subject. This commentary brings forth several considerations that are 
perceived on reading this article. First, although innovation strategies are important for the dynamicity of 
health systems, one should discuss whether or not RIH can adequately address equity and sustainability on a 
global scale. Secondly, RIH across countries should also be debated in the context of the principles garnered by 
the type of health system, thereby identifying whether or not the prevailing political goals support equity and 
sustainability, and whether or not policy-makers are adequately supported to translate system-level demand 
signals into innovation development opportunities. As key messages, the commentary reiterates the emphasis 
made by the authors of the need for international policy-oriented fora as learning vehicles on RIH that also 
address system-level challenges, albeit the need to acknowledge cultural differences. In addition, the public has 
not only the right for transparency on how equity and sustainability challenges are addressed in innovation 
decisions, but also the responsibilities to contribute to overcome these challenges. 
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The insights from an international scoping review provided by Lehoux et al challenge health policy-makers, entrepreneurs/innovators and users of 
healthcare, worldwide, to be aware of equity and sustainability 
challenges at system-level when appraising responsible 
innovation in health (RIH) – purposefully designed to better 
support health systems.1 Equity in health is “the absence 
of systematic disparities in health (or in the major social 
determinants of health) between groups with different levels 
of underlying social advantage/disadvantage—that is, wealth, 
power, or prestige” (p. 254).2 Although there is no widely-used 
definition of sustainability in healthcare, in this commentary, 
I will refer to it as a key task for health policy-makers to 
withstand social, financial, and ecological pressures and 
challenges.3
The authors highlight interesting research gaps that 
inspired them to conduct the international scoping review, 
namely that “few attempts have been made to articulate what 
system-level challenges RIH should seek to address” and “one 
may wonder why health services and policy researchers have 
not yet sought to synthesize what is known about system-
level challenges that innovations should attend to in the 
first place.” Specifically, the authors frame the discourse on 
innovation against the population health goals of equity and 
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sustainability. Indeed, the review enabled the authors to fill 
these gaps by putting structure to the complex and somewhat 
fragmented issues surrounding health-system’ demands 
for innovations, and utilizing van Omen et al’s analytical 
framework4 to argue that innovations may affect several 
health system components simultaneously, and that some 
innovations may alleviate, while others exacerbate equity and 
sustainability challenges. What comes out very clearly is that 
it is somewhat difficult for health innovators to satisfy RIH’s 
definition in its entirety and therefore the “ethical, economic, 
social and environmental principles, values and requirements 
when they design, finance, produce, distribute, use and discard 
sociotechnical solutions to address the needs and challenges 
of health systems in a sustainable way.”5 Likewise, it is taxing 
for policy-makers to strain health systems’ financing and 
governance so as to enable diffusion of medical technologies. 
In other words, health policy-makers and other stakeholders 
experience ethical dilemmas on a daily basis in their bid to 
keep up with medical innovations, yet strive to reach the 
optimal trade-off between competing demands, equity and 
sustainability. In this commentary, I will refer to healthcare in 
general with examples cutting across different specializations 
and disciplines, since all these contribute in one way or other 
to population health.
This commentary brings forth the following considerations 
on this article.
Innovation Strategies
Lehoux et al manage to extract no less than 1391 health system 
challenges with those mostly cited pertaining to service 
delivery, human resources, leadership and governance.1 This 
fits within the analytical framework adapted from Olmen et 
al.2 The findings support the innovation strategy of building 
capacity, resources, knowledge, skills etc as part of an 
innovation-friendly infrastructure. The challenge that arises 
is that not all countries, in particular those classified as the 
lower income ones, can afford to build up this infrastructure 
that is needed to support the innovation strategy. The limited 
governance structures found in most low-income countries 
may also be the cause for the failure in implementing any form 
of innovation strategy, even if resources are made available by 
richer countries.6,7 Therefore, the attainment of global equity 
and sustainability is near to impossible to achieve because 
of the multifactorial conditions that need to be in place for 
the innovation strategies to work. Rightly so, the authors 
classify countries according to the Human Development 
Index (HDI) – a proxy for population health as it considers 
life expectancy at birth, mean years of schooling and expected 
years of schooling, and gross national income per capita. The 
discourse on equity is of an ethical nature, and based on the 
principles of distributive justice in a bid to allocate scarce 
resources in a fair and just manner. Interestingly, the authors 
acknowledge that Brazil, India, China, and South Africa are 
active in health innovation development, even though they 
are outside the Organization for Economic Cooperation 
and Development, which provides unity among member 
countries to share common eco-social problems, as well as 
collaborate on finding solutions. While this is promising in 
that the ‘poorer’ countries are important players in innovation, 
a comparison of the historical medical spending patterns 
among the BRICS (Brazil, Russia, India, China, and South 
Africa) and G7 countries reveals that the egalitarian principle 
of global equity is not supported in view of the gross global 
wealth inequality in relation to the size of the population 
served – which is reflected in health spending.8 Indeed, the 
BRICS’ populations’ actual health needs – reflected by the 
socio-economic determinants, are far greater than those of 
G7 countries, yet the their share of Total Health Expenditure 
is far less.8 
Witty9 attempts to suggest new strategies for innovation 
in global health by taking the pharmaceutical perspective. 
He argues that since pharmaceutical industries are the ones 
driving crucial research into new vaccines and medicines to 
combat diseases that disproportionately affect developing 
countries, they need to be supported to secure financial 
returns that safeguards their investment in neglected and 
less lucrative diseases. Witty9 claims that “the public and 
private sectors must work together to develop a wide range 
of innovative tools, partnerships and approaches” (p. 118). 
Among these include an open innovation strategy that 
redesigns sharing intellectual property, resources, and data 
– and therefore introducing flexibility, easier accessibility 
to libraries and collections of molecular entities, as well as 
opportunities for external researchers to work alongside 
company scientists. 
The crisis from emerging zoonosis like Ebola led to 
stakeholders worldwide to adopt a One Health approach.10 
This applies to innovations, as the smart way of achieving 
equity and sustainability in addressing ‘wicked’ problems that 
have eluded policy-makers for so long is the transdisciplinary 
collaboration in ensuring sharing of new knowledge, skills, 
technologies and infrastructure.11 Wicked problems are 
challenging, multifaceted, and intractable healthcare issues 
that contribute disproportionately to reduced quality of life, 
chronic health conditions, and high healthcare utilization.12 
Examples include stigmatized conditions, such as obesity, 
substance use disorders, and domestic violence, which could 
be addressed by innovative systems, quality improvement 
methodologies, health information technologies, and 
implementation science.12
This is in line with RIH which as cited by Lehoux et al is 
understood as a “collaborative endeavor wherein stakeholders 
are committed to clarify and meet a set of ethical, economic, 
social and environmental principles, values and requirements 
when they design, finance, produce, distribute, use and 
discard sociotechnical solutions to address the needs and 
challenges of health systems in a sustainable way.” 
Other strategies suggested by Witty9 is redesigning 
financing schemes and pricing models to boost private sector 
investment in drug/vaccine research and development, as well 
as the dissemination, diffusion, adoption and implementation 
of existing technologies, therapies for developing countries. 
Finally, adopting a disruptive innovation strategy is 
more likely to reach populations far and wide. Disruptive 
innovations in healthcare replace existing services by low-
cost alternatives in what is deemed to be “Uber’s message for 
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healthcare.”13 Examples include the various types of point-
of-care testing at the emergency department, for example 
use of troponin testing for acute coronary syndrome and 
abdominal ultrasound for blunt abdominal trauma, that are 
now increasingly saving lives in emergency situations.14 
Health Systems’ Guiding Principles and Political Agenda 
Prevailing in Country 
Lehoux et al1 classified countries according to HDI, while 
justifying their decision not to classify them according to the 
types of health systems on the basis that the articles reviewed 
studied a specific setting within a broader national or regional 
health system. However, RIH across countries should also be 
discussed in the context of the principles garnered by the 
type of health system, thereby identifying whether or not the 
prevailing political goals support equity and sustainability, 
and whether or not policy-makers are adequately supported 
to translate system-level demand signals into innovation 
development opportunities. Interestingly, principles and 
values were scantly reported as system-level challenges for RIH 
across the spectrum of HDI countries and may be considered 
an important research gap to fill. The slow diffusion, adoption 
and implementation, as well as the attainment of equity and 
sustainability of RIH, may also be researched by reviewing 
the context in which they were borne, namely the guiding 
principles, environmental and operational characteristics 
of the healthcare system.15 Berwick identified politics and 
red tape as barriers to innovation.16 The guiding principles, 
namely commitment to solidarity, equity and universality 
are not given equal importance across health systems and 
therefore system-levels goals of RIH are not the same across 
countries. These differences may also influence the transfer 
of innovations across systems. For example, the rivate mixed 
health services model of the United States is based on the 
principles of high quality of care, advanced medical technology 
and best models of specialist care but less on solidarity and 
commitment to universal coverage. In contrast, the state as 
owner model (as in United Kingdom) or the state as guardian 
model (as in Germany) of health services are based on the 
principles of solidarity and universality.15 The latter however 
seems to be more successful at adopting a consumer-driven 
approach at innovation than the former.
Conclusion
This commentary provides some insights from the well-
structured and researched international scoping review on 
RIH by Lehoux et al.1 This review is an important contribution 
to the subject and puts forth the emphasis that stakeholders 
involved in healthcare innovation should not be short-sighted 
and focus simply on the innovation as an invention but go 
beyond this into the realm of RIH that also overcomes system-
level challenges of equity and sustainability. This commentary 
invites readers to also consider innovation strategies that 
may bring about this as well as look at the guiding principles 
of health and political systems across countries that may 
hinder the attainment of innovation diffusion and global 
equity in the health of populations. Finally, this commentary 
reiterates the emphasis made by the authors of the need for 
international policy-oriented fora as learning vehicles on 
RIH that also address system-level challenges, albeit the 
need to acknowledge cultural differences. In addition, the 
public has not only the right for transparency on how equity 
and sustainability challenges are addressed in innovation 
decisions, but also the responsibilities to contribute to 
overcome these challenges.
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